ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00921167
Recruitment Status : Completed
First Posted : June 16, 2009
Last Update Posted : December 4, 2013
Sponsor:
Collaborator:
Seoul National University Hospital
Information provided by (Responsible Party):
Clinical Research Center for Solid Tumor, Korea

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : December 2013